Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on: March 12,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on:March 12,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on: May 25,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on:May 25,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on: December 01,2024

A new screening tool improves liver cancer detection

by Jordan Shaked,Yale UniversityTen-year risk of hepatocellular carcinoma (HCC). Credit:JAMA Network Open(2024). DOI: 10.1001/jamanetworkopen.2024.43608Hepatocellular carcinoma, a ty

Updated on:December 01,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on: February 03,2024

Study provides new look at why rare cancer often evades treatments

by Boston Medical CenterCharacterizing the cellular landscape of pancreatic, small intestinal, and gNETs. (A) NET scRNA-seq workflow. Resected tumor fragments were dissociated into single-cell su

Updated on:February 03,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on: January 30,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on:January 30,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on: April 09,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on:April 09,2024

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st

Updated on: May 05,2024

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st

Updated on:May 05,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on: February 23,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on:February 23,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on: March 01,2024

Study sheds new light on mechanism of breast cancer treatment resistance

by Dana-Farber Cancer InstituteMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainA study by researchers at Dana-Farber Cancer Institute has illumina

Updated on:March 01,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on: January 30,2024

Study: Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer

by Impact Journals LLCResponse to docetaxel in second or third line treatment for non-small cell lung cancer after a treatment with chemo-immunotherapy. Credit:Oncotarget(2023). DOI: 10.18

Updated on:January 30,2024

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr

Updated on: January 02,2024

Genetic testing for prostate cancer increases after introduction of point-of-care program

byWolters Kluwer HealthCredit: Unsplash/CC0 Public DomainSome patients with prostate cancer have genetic mutations that may impact their treatment. A comprehensive, on-site genetic testing progr

Updated on:January 02,2024